Idioma:

Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex

Zhang, Xiaojun ; Glunz, Peter W ; Johnson, James A ; Jiang, Wen ; Jacutin-Porte, Swanee ; Ladziata, Vladimir ; Zou, Yan ; Phillips, Monique S ; Wurtz, Nicholas R ; Parkhurst, Brandon ; Rendina, Alan R ; Harper, Timothy M ; Cheney, Daniel L ; Luettgen, Joseph M ; Wong, Pancras C ; Seiffert, Dietmar ; Wexler, Ruth R ; Priestley, E. Scott

Journal of medicinal chemistry, 2016-08, Vol.59 (15), p.7125-7137 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por

Enviar para

Título:
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex
Autor: Zhang, Xiaojun ; Glunz, Peter W ; Johnson, James A ; Jiang, Wen ; Jacutin-Porte, Swanee ; Ladziata, Vladimir ; Zou, Yan ; Phillips, Monique S ; Wurtz, Nicholas R ; Parkhurst, Brandon ; Rendina, Alan R ; Harper, Timothy M ; Cheney, Daniel L ; Luettgen, Joseph M ; Wong, Pancras C ; Seiffert, Dietmar ; Wexler, Ruth R ; Priestley, E. Scott
Assuntos: Administration, Oral ; Animals ; Anticoagulants - administration & dosage ; Anticoagulants - chemistry ; Anticoagulants - pharmacology ; Biological Availability ; Dogs ; Dose-Response Relationship, Drug ; Drug Discovery ; Factor VIIa - antagonists & inhibitors ; Factor VIIa - metabolism ; Healthy Volunteers ; Humans ; Macrocyclic Compounds - administration & dosage ; Macrocyclic Compounds - chemistry ; Macrocyclic Compounds - pharmacology ; Male ; Models, Molecular ; Molecular Structure ; Rabbits ; Structure-Activity Relationship ; Thromboplastin - antagonists & inhibitors ; Thromboplastin - metabolism
É parte de: Journal of medicinal chemistry, 2016-08, Vol.59 (15), p.7125-7137
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Inhibitors of the tissue factor (TF)/factor VIIa complex (TF-FVIIa) are promising novel anticoagulants which show excellent efficacy and minimal bleeding in preclinical models. Starting with an aminoisoquinoline P1-based macrocyclic inhibitor, optimization of the P′ groups led to a series of highly potent and selective TF-FVIIa inhibitors which displayed poor permeability. Fluorination of the aminoisoquinoline reduced the basicity of the P1 group and significantly improved permeability. The resulting lead compound was highly potent, selective, and achieved good pharmacokinetics in dogs with oral dosing. Moreover, it demonstrated robust antithrombotic activity in a rabbit model of arterial thrombosis.
Editor: United States: American Chemical Society
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex

United States: American Chemical Society

Buscando em bases de dados remotas. Favor aguardar.